Cocrystal Pharma (COCP) Shares Outstanding (2010 - 2026)

Cocrystal Pharma (COCP) has 13 years of Shares Outstanding (Entity) data on file, last reported at $13.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 35.51% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (up 35.51% YoY), and the FY2025 full-year result was $11.3 million, up 10.97% from the prior year.
• Shares Outstanding (Entity) advanced to $13.8 million in Q1 2026, from $11.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $13.8 million in Q1 2026 to a low of $8.1 million in Q1 2022.
• A 5-year average of $10.0 million and a median of $10.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Peak annual rise in Shares Outstanding (Entity) reached 100158.56% in 2022, while the deepest fall reached 0.0% in 2022.
• Tracing COCP's Shares Outstanding (Entity) over 5 years: stood at $8.1 million in 2022, then increased by 24.94% to $10.2 million in 2023, then changed by 0.0% to $10.2 million in 2024, then advanced by 10.97% to $11.3 million in 2025, then increased by 22.12% to $13.8 million in 2026.
• Business Quant data shows COCP's Shares Outstanding (Entity) at $13.8 million in Q1 2026, $11.3 million in Q4 2025, and $13.0 million in Q3 2025.